دورية أكاديمية
Indication of endovascular treatment of type B aortic dissection--literature review.
| العنوان: | Indication of endovascular treatment of type B aortic dissection--literature review. |
|---|---|
| المؤلفون: | Duarte JJ; Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil., Pontes JC; Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil., Benfatti RA; Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil., Ferrachini AL; Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil., Karakhanian WK; Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, SP, Brazil., Razuk Filho A; Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, SP, Brazil. |
| المصدر: | Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular [Rev Bras Cir Cardiovasc] 2014 Jul-Sep; Vol. 29 (3), pp. 396-401. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Sociedade Brasileira de Cirurgia Cardiovascular Country of Publication: Brazil NLM ID: 9104279 Publication Model: Print Cited Medium: Internet NLM ISO Abbreviation: Rev Bras Cir Cardiovasc Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: São Paulo, SP, Brasil : Sociedade Brasileira de Cirurgia Cardiovascular |
| مواضيع طبية MeSH: | Aortic Dissection/*surgery , Aortic Aneurysm, Thoracic/*surgery , Endovascular Procedures/*methods, Aortic Dissection/mortality ; Aortic Aneurysm, Thoracic/mortality ; Endovascular Procedures/mortality ; Hospital Mortality ; Humans ; Randomized Controlled Trials as Topic ; Treatment Outcome |
| مستخلص: | Aortic dissection is a cardiovascular event of high mortality if not early diagnosed and properly treated. In Stanford type A aortic dissection, there is the involvement of the ascending aorta, whereas in type B the ascending aorta is not affected. The treatment of type A aortic dissection is mainly surgical. The hospital mortality of type B aortic dissection surgical treatment is approximately 20%, while medical therapy is 10%. However, half the patients who are discharged from hospital after medical treatment, progress to aortic complications in the following years, and the mortality in three to five years may reach 25-50%. In addition, the surgical treatment of aortic complications after medical treatment, has also a significant mortality. This way, the endovascular treatment comes up as an interesting alternative of a less invasive treatment for this disease. They presented a mortality rate lower than 10% with more than 80% success rate of occlusion and thrombosis of the false lumen. The INSTEAD TRIAL, which randomized patients with uncomplicated type B aortic dissection for optimal medical therapy and endovascular treatment in addition to optimal medical therapy, showed that after three years of follow up, patients who underwent endovascular treatment had lower mortality and aorta-related complications. Therefore, there is a current tendency to recommend the endovascular treatment as a standard for the treatment of type B aortic dissection. |
| References: | Rev Bras Cir Cardiovasc. 2007 Oct-Dec;22(4):441-7. (PMID: 18488111) Circulation. 2002 Sep 24;106(12 Suppl 1):I234-40. (PMID: 12354739) Vestn Khir Im I I Grek. 1986 Nov;137(11):123-5. (PMID: 3824776) Circ Cardiovasc Interv. 2013 Aug;6(4):407-16. (PMID: 23922146) N Engl J Med. 1999 May 20;340(20):1546-52. (PMID: 10332016) J Endovasc Ther. 2002 Dec;9(6):822-8. (PMID: 12546584) JAMA. 2000 Feb 16;283(7):897-903. (PMID: 10685714) N Engl J Med. 1999 May 20;340(20):1539-45. (PMID: 10332015) Radiology. 2000 Nov;217(2):544-50. (PMID: 11058658) Eur J Cardiothorac Surg. 2008 Jan;33(1):58-63. (PMID: 18024145) J Vasc Surg. 2004 Oct;40(4):670-9; discussion 679-80. (PMID: 15472593) J Vasc Interv Radiol. 2003 Feb;14(2 Pt 1):195-203. (PMID: 12582187) Eur Heart J. 2005 Mar;26(5):489-97. (PMID: 15673541) Ann Thorac Surg. 2004 Oct;78(4):1268-73. (PMID: 15464484) Circulation. 1995 Nov 1;92(9 Suppl):II113-21. (PMID: 7586393) Circulation. 2005 Jun 7;111(22):2951-7. (PMID: 15927978) Arq Bras Cardiol. 1998 Jun;70(6):389-2. (PMID: 9713079) JACC Cardiovasc Interv. 2013 Aug;6(8):876-82. (PMID: 23968705) J Endovasc Ther. 2005 Oct;12(5):620-1. (PMID: 16212465) Ann Thorac Surg. 2007 Mar;83(3):1059-66. (PMID: 17307460) Circulation. 2004 Sep 14;110(11 Suppl 1):II262-7. (PMID: 15364873) Circulation. 2002 Sep 24;106(12 Suppl 1):I241-7. (PMID: 12354740) Eur J Cardiothorac Surg. 2005 May;27(5):826-30. (PMID: 15848321) Ann Vasc Surg. 1991 Nov;5(6):491-9. (PMID: 1837729) Eur Heart J. 2006 Feb;27(4):489-98. (PMID: 16227309) Am Heart J. 2005 Apr;149(4):592-9. (PMID: 15990739) Eur J Cardiothorac Surg. 2004 Aug;26(2):359-66. (PMID: 15296897) N Engl J Med. 2007 Jul 26;357(4):349-59. (PMID: 17652650) J Vasc Surg. 2003 Jan;37(1):100-5. (PMID: 12514584) Ann Thorac Surg. 1997 Apr;63(4):1081-4. (PMID: 9124909) J Thorac Cardiovasc Surg. 2009 Oct;138(4):865-72. (PMID: 19660348) Ann Thorac Surg. 2012 Apr;93(4):1215-22. (PMID: 22402280) N Engl J Med. 1994 Dec 29;331(26):1729-34. (PMID: 7984192) Circulation. 2009 Dec 22;120(25):2519-28. (PMID: 19996018) Rev Bras Cir Cardiovasc. 2011 Apr-Jun;26(2):250-7. (PMID: 21894416) J Thorac Cardiovasc Surg. 2006 Aug;132(2):361-8. (PMID: 16872963) Interact Cardiovasc Thorac Surg. 2006 Dec;5(6):746-8. (PMID: 17670703) |
| تواريخ الأحداث: | Date Created: 20141106 Date Completed: 20150518 Latest Revision: 20221207 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC4412331 |
| DOI: | 10.5935/1678-9741.20140076 |
| PMID: | 25372915 |
| قاعدة البيانات: | MEDLINE |
| DOI: | 10.5935/1678-9741.20140076 |
|---|